drugset / Trial / NCT00808769

Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression

NCT00808769

Phase 4 Completed 30 enrolled Procter and Gamble
RandomizedCrossoverSingle-blind

Summary

The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.

Timeline

Start
2008-11
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified 20 mg
Subject Omeprazole Other / unclassified 20.6 mg

Indications

No indication recorded.